Alcohol and Alcoholism Advance Access originally published online on November 18, 2004
Alcohol and Alcoholism 2005 40(2):155-156; doi:10.1093/alcalc/agh106
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Alcohol & Alcoholism Vol. 40, No. 2 © Medical Council on Alcohol 2005; all rights reserved
LETTER TO THE EDITOR
THIAMINE ADMINISTRATION IN ALCOHOL-DEPENDENT PATIENTS
Bernard B. Brodie Department of Neuroscience, University of Cagliari, Viale Diaz, 182, 1-09126 Cagliari, Italy
(Received 28 August 2004; first review notified 12 September 2004; in revised form 28 September 2004; accepted 7 October 2004)
| The first 10% of the full text of this article appears below. |
Thiamine (vitamin B1) is a water-soluble vitamin that is involved in the metabolism of glucose and lipids as well as in the production of glucose-derived neurotransmitters (see Cook et al., 1998
). Its deficiency leads to a variety of neurological and cardiovascular symptoms and signs. Early symptoms may include fatigue, weakness and emotional disturbance, whereas prolonged gradual deficiency may lead to a form of polyneuritis (known as dry beriberi), cardiac failure or peripheral oedema (wet beriberi) (Thomson, 2000
).
Severe thiamine deficiency (TD) may result in the
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. D. THOMSON and E. J. MARSHALL THE TREATMENT OF PATIENTS AT RISK OF DEVELOPING WERNICKE'S ENCEPHALOPATHY IN THE COMMUNITY Alcohol Alcohol., March 1, 2006; 41(2): 159 - 167. [Abstract] [Full Text] [PDF] |
||||
